MedTrace Logo

Prospective Clinical Trial to Evaluate the Safety and Effectiveness of the IOL

NCT03451786 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 369

Last updated 2023-04-11

Study results available
· View outcomes & findings →

Summary

To establish the safety and effectiveness of the CT LUCIA 611P posterior chamber intraocular lens for the correction of aphakia following extracapsular cataract extraction via phacoemulsification in adult patients.

Conditions

  • Cataract Unilateral
  • Aphakia

Interventions

DEVICE

IOL

Intraocular lens

Sponsors & Collaborators

  • Estelle Poineau

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-23
Primary Completion
2020-03-12
Completion
2020-03-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03451786 on ClinicalTrials.gov